These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32168417)

  • 81. Phase 2 Study of Acupuncture-Like Transcutaneous Nerve Stimulation for Chemotherapy-Induced Peripheral Neuropathy.
    Wong R; Major P; Sagar S
    Integr Cancer Ther; 2016 Jun; 15(2):153-64. PubMed ID: 27130723
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer.
    Leonard GD; Wright MA; Quinn MG; Fioravanti S; Harold N; Schuler B; Thomas RR; Grem JL
    BMC Cancer; 2005 Sep; 5():116. PubMed ID: 16168057
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Predictors for development of oxaliplatin-induced peripheral neuropathy in cancer patients as determined by ordered logistic regression analysis.
    Kanbayashi Y; Ishikawa T; Kuriu Y; Otsuji E; Takayama K
    PLoS One; 2022; 17(9):e0275481. PubMed ID: 36174022
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Electronic von Frey as an objective assessment tool for oxaliplatin-induced peripheral neuropathy: A prospective longitudinal study.
    Godinho PAR; Silva PGB; Lisboa MRP; Costa BA; Gifoni MAC; Rocha Filho DR; Lima-Júnior RCP; Vale ML
    Eur J Cancer Care (Engl); 2021 Jan; 30(1):e13360. PubMed ID: 33219575
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer.
    Argyriou AA; Cavaletti G; Briani C; Velasco R; Bruna J; Campagnolo M; Alberti P; Bergamo F; Cortinovis D; Cazzaniga M; Santos C; Papadimitriou K; Kalofonos HP
    Cancer; 2013 Jan; 119(2):438-44. PubMed ID: 22786764
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The course of peripheral neuropathy and its association with health-related quality of life among colorectal cancer patients.
    Bonhof CS; van de Poll-Franse LV; Wasowicz DK; Beerepoot LV; Vreugdenhil G; Mols F
    J Cancer Surviv; 2021 Apr; 15(2):190-200. PubMed ID: 33185839
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effect of Exercise on Taxane Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Randomized Controlled Trial.
    Bland KA; Kirkham AA; Bovard J; Shenkier T; Zucker D; McKenzie DC; Davis MK; Gelmon KA; Campbell KL
    Clin Breast Cancer; 2019 Dec; 19(6):411-422. PubMed ID: 31601479
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients.
    Wang WS; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chiou TJ; Liu JH; Yen CC; Chen PM
    Oncologist; 2007 Mar; 12(3):312-9. PubMed ID: 17405895
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Sweet bee venom pharmacopuncture for chemotherapy-induced peripheral neuropathy.
    Yoon J; Jeon JH; Lee YW; Cho CK; Kwon KR; Shin JE; Sagar S; Wong R; Yoo HS
    J Acupunct Meridian Stud; 2012 Aug; 5(4):156-65. PubMed ID: 22898064
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Early Neuropathy Related to Oxaliplatin Treatment in Advanced and Recurrent Colorectal Cancer.
    Nagata T; Fukuda KI; Tamai M; Taniguchi A; Kamiya H; Kambe K; Kamada Y; Iwata G; Yamaoka N
    Anticancer Res; 2019 Mar; 39(3):1347-1353. PubMed ID: 30842168
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Daily activity, mood, and quality of life in colorectal cancer patients with chemotherapy-induced peripheral neuropathy: A mediation effect analysis.
    Lu LC; Tsay SL; Chang SY; Chen CM; Liu CY
    Cancer Med; 2019 Mar; 8(3):963-971. PubMed ID: 30741481
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Acute chemotherapy-induced peripheral neuropathy due to oxaliplatin administration without cold stimulation.
    Matsumoto Y; Yoshida Y; Kiba S; Yamashiro S; Nogami H; Ohashi N; Kajitani R; Munechika T; Nagano H; Komono A; Aisu N; Yoshimatsu G; Hasegawa S
    Support Care Cancer; 2020 Nov; 28(11):5405-5410. PubMed ID: 32144582
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Qualitative Evaluation of the Influence of Acute Oxaliplatin-Induced Peripheral Neuropathy on Quality of Life and Activities of Daily Life.
    van Haren FGAM; Steegers MAH; Thijssen M; van der Wal SEI; Vissers KCP; Engels Y
    Pain Pract; 2021 Jun; 21(5):513-522. PubMed ID: 33301649
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The preliminary effects of henna on chemotherapy-induced peripheral neuropathy in women receiving oxaliplatin-based treatment: A parallel-group, randomized, controlled pilot trial.
    Arslan S; Zorba Bahceli P; İlik Y; Artaç M
    Eur J Oncol Nurs; 2020 Oct; 48():101827. PubMed ID: 32932009
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY).
    Tanioka H; Nagasaka T; Uno F; Inoue M; Okita H; Katata Y; Kanzaki H; Kuramochi H; Satake H; Shindo Y; Doi A; Nasu J; Yamashita H; Yamaguchi Y
    BMC Cancer; 2019 Oct; 19(1):941. PubMed ID: 31604467
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A Prospective Study of Chronic Oxaliplatin-Induced Neuropathy in Patients with Colon Cancer: Long-Term Outcomes and Predictors of Severe Oxaliplatin-Induced Neuropathy.
    Kim SH; Kim W; Kim JH; Woo MK; Baek JY; Kim SY; Chung SH; Kim HJ
    J Clin Neurol; 2018 Jan; 14(1):81-89. PubMed ID: 29629544
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development.
    Yang Y; Zhao B; Gao X; Sun J; Ye J; Li J; Cao P
    J Exp Clin Cancer Res; 2021 Oct; 40(1):331. PubMed ID: 34686205
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Nrf2 inhibits oxaliplatin-induced peripheral neuropathy via protection of mitochondrial function.
    Yang Y; Luo L; Cai X; Fang Y; Wang J; Chen G; Yang J; Zhou Q; Sun X; Cheng X; Yan H; Lu W; Hu C; Cao P
    Free Radic Biol Med; 2018 May; 120():13-24. PubMed ID: 29530794
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx).
    Cheng HL; Molassiotis A
    Asia Pac J Clin Oncol; 2019 Feb; 15(1):56-62. PubMed ID: 29873180
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The Feasibility and Effects of Acupuncture on Quality of Life Scores During Chemotherapy in Ovarian Cancer: Results from a Pilot, Randomized Sham-Controlled Trial.
    Lu W; Matulonis UA; Dunn JE; Lee H; Doherty-Gilman A; Dean-Clower E; Goodman A; Davis RB; Buring J; Wayne P; Rosenthal DS; Penson RT
    Med Acupunct; 2012 Dec; 24(4):233-240. PubMed ID: 24761165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.